title: Ocular toxicity related to cetuximab monotherapy in an advanced colorectal cancer patient.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Tonini
authors.forename: Bruno
authors.initials: B
authors.lastname: Vincenzi
authors.forename: Daniele
authors.initials: D
authors.lastname: Santini
authors.forename: Diego
authors.initials: D
authors.lastname: Olzi
authors.forename: Alessandro
authors.initials: A
authors.lastname: Lambiase
authors.forename: Stefano
authors.initials: S
authors.lastname: Bonini
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001762:Blepharitis / Q000139:chemically induced* / Q000473:pathology; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D000068818:Cetuximab